Foramen ovale (heart)

From WikiMD's WELLNESSPEDIA

The foramen ovale is an important anatomical feature in the fetal circulation system. It is an opening in the septum between the right atrium and the left atrium of the heart. This opening allows blood to bypass the non-functioning fetal lungs and flow directly from the right atrium to the left atrium.

Development[edit]

The foramen ovale forms during the development of the fetal heart. It is a crucial component of the fetal circulation system, which includes the ductus arteriosus and the ductus venosus. These structures work together to ensure that oxygenated blood from the placenta is efficiently distributed throughout the fetus.

Function[edit]

In the fetus, the foramen ovale allows oxygen-rich blood from the umbilical vein to pass from the right atrium to the left atrium. This blood then enters the left ventricle and is pumped into the aorta, supplying the body with oxygenated blood. This bypass of the lungs is necessary because the fetal lungs are not yet functional and are filled with fluid.

Closure[edit]

After birth, the foramen ovale typically closes as the newborn begins to breathe and the pulmonary circulation becomes functional. The increased pressure in the left atrium, due to the influx of blood from the lungs, forces the foramen ovale to close. In most individuals, this closure is permanent, and the foramen ovale becomes the fossa ovalis.

Patent Foramen Ovale[edit]

In some individuals, the foramen ovale does not close completely after birth, resulting in a condition known as patent foramen ovale (PFO). A PFO can allow blood to flow between the atria, which may lead to various health issues, including an increased risk of stroke and migraines.

Clinical Significance[edit]

The presence of a patent foramen ovale can be detected using diagnostic tools such as echocardiography. Treatment options for PFO may include medical management or surgical intervention, depending on the severity of the condition and the presence of symptoms.

See Also[edit]





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.